No photo of Lakshmi Rajdev

View Scopus Profile

Lakshmi Rajdev, M.B.,B.S.

  • 648 Citations
  • 14 h-Index
20002020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Lakshmi Rajdev is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 28 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Publications

  • 648 Citations
  • 14 h-Index
  • 20 Article
  • 13 Review article
  • 1 Editorial

Impact and diagnostic gaps of comprehensive genomic profiling in real-world clinical practice

Singh, A. P., Shum, E., Rajdev, L., Cheng, H., Goel, S., Perez-Soler, R. & Halmos, B., May 2020, In : Cancers. 12, 5, 1156.

Research output: Contribution to journal › Article

Open Access

    • Assessment of Treatment with Sorafenib Plus Doxorubicin vs Sorafenib Alone in Patients with Advanced Hepatocellular Carcinoma: Phase 3 CALGB 80802 Randomized Clinical Trial

    Abou-Alfa, G. K., Shi, Q., Knox, J. J., Kaubisch, A., Niedzwiecki, D., Posey, J., Tan, B. R., Kavan, P., Goel, R., Lammers, P. E., Bekaii-Saab, T. S., Tam, V. C., Rajdev, L., Kelley, R. K., El Dika, I., Zemla, T., Potaracke, R. I., Balletti, J., El-Khoueiry, A. B., Harding, J. J. & 7 others, Suga, J. M., Schwartz, L. H., Goldberg, R. M., Bertagnolli, M. M., Meyerhardt, J., O'Reilly, E. M. & Venook, A. P., Nov 2019, In : JAMA Oncology. 5, 11, p. 1582-1588 7 p.

    Research output: Contribution to journal › Article

    • 2 Scopus citations

    Comparing outcomes following total neoadjuvant therapy and following neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer

    Zhu, S., Brodin, N. P., English, K., Ohri, N., Chuy, J. W., Rajdev, L. N., Narang, R., Kalnicki, S., Guha, C., Garg, M. K. & Kabarriti, R., Nov 2019, In : EClinicalMedicine. 16, p. 23-29 7 p.

    Research output: Contribution to journal › Article

    Open Access
    • 1 Scopus citations

    Excision repair cross-complementing group-1 (ERCC1) induction kinetics and polymorphism are markers of inferior outcome in patients with colorectal cancer treated with oxaliplatin

    Rao, D., Mallick, A. B., Augustine, T., Daroqui, C., Jiffry, J., Merla, A., Chaudhary, I., Seetharam, R., Sood, A., Gajavelli, S., Aparo, S., Rajdev, L., Kaubisch, A., Chuy, J., Negassa, A., Mariadason, J. M., Maitra, R. & Goel, S., Jan 1 2019, In : Oncotarget. 10, 53, p. 5510-5522 13 p.

    Research output: Contribution to journal › Article

    • Human papillomavirus, radiation dose and survival of patients with anal cancer

    Kabarriti, R., Brodin, N. P., Ohri, N., Narang, R., Huang, R., Chuy, J. W., Rajdev, L. N., Kalnicki, S., Guha, C. & Garg, M. K., Dec 2 2019, In : Acta Oncologica. 58, 12, p. 1745-1751 7 p.

    Research output: Contribution to journal › Article

    • 1 Scopus citations